Among patients with newly diagnosed epilepsy, nearly 1 in 3 do not receive antiepileptic drugs (AEDs) initially, according to researchers in Australia.
They studied treatment patterns in patients referred to seizure specialty clinics in Western Australia. Of the 610 patients with a clear diagnosis of epilepsy, 189 (31%) did not start AED treatment at the time of diagnosis. This included 16.4% who were not offered treatment and 14.6% who declined treatment.
Common reasons neurologists gave for not offering treatment included a history of only 1 seizure (30%), pending results for additional tests (29%), or the presence of seizure-precipitating factors (22%).
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.